Scarica l'app Stockscreener
1.86
2.11%
-0.04
Dopo l'orario di chiusura:
1.87
0.01
+0.54%
Precedente Chiudi:
$1.90
Aprire:
$1.91
Volume 24 ore:
3.47M
Relative Volume:
0.93
Capitalizzazione di mercato:
$303.14M
Reddito:
-
Utile/perdita netta:
$-111.13M
Rapporto P/E:
-1.4091
EPS:
-1.32
Flusso di cassa netto:
$-91.53M
1 W Prestazione:
-7.92%
1M Prestazione:
+47.62%
6M Prestazione:
+302.68%
1 anno Prestazione:
+6.29%
Intervallo 1D:
$1.85
$2.02
Intervallo di 1 settimana:
$1.80
$2.35
Portata 52W:
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Nome
Tenaya Therapeutics Inc
Settore
Industria
Telefono
415-865-2066
Indirizzo
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Confronta TNYA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
1.86 | 325.95M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-10 | Iniziato | William Blair | Outperform |
| 2023-11-30 | Iniziato | Leerink Partners | Outperform |
| 2022-06-15 | Iniziato | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Borsa (TNYA) Ultime notizie
Statistical indicators supporting Tenaya Therapeutics Inc.’s strength2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - newser.com
Does Tenaya Therapeutics Inc. qualify in momentum factor screeningMarket Activity Recap & Verified Swing Trading Watchlists - newser.com
Should you wait for a breakout in Tenaya Therapeutics Inc.2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
Does Tenaya Therapeutics Inc. show high probability of rebound2025 Earnings Surprises & High Return Stock Watch Alerts - newser.com
Is Tenaya Therapeutics Inc. still worth holding after the dipWeekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
Will Tenaya Therapeutics Inc. stock continue dividend increases2025 EndofYear Setup & Technical Pattern Based Signals - newser.com
Momentum divergence signals in Tenaya Therapeutics Inc. chartM&A Rumor & AI Based Trade Execution Alerts - newser.com
Applying chart zones and confluence areas to Tenaya Therapeutics Inc.Weekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Intraday pattern recognizer results for Tenaya Therapeutics Inc.July 2025 Outlook & Short-Term Trading Alerts - newser.com
What Fibonacci levels say about Tenaya Therapeutics Inc. reboundJuly 2025 PostEarnings & Risk Controlled Stock Pick Alerts - newser.com
What to expect from Tenaya Therapeutics Inc. in the next 30 daysJuly 2025 Highlights & Fast Entry High Yield Tips - newser.com
What analysts say about Tenaya Therapeutics Inc stockEarnings Call Summaries & Affordable Growth Trading - earlytimes.in
Tenaya Therapeutics (TNYA): Evaluating Valuation After Investor Buzz on MyPEAK-1 and RIDGE-1 Clinical Updates - Yahoo Finance
Real time scanner hits for Tenaya Therapeutics Inc. explainedEarnings Trend Report & Verified Entry Point Signals - newser.com
Tenaya Therapeutics Stock (TNYA) Opinions on CEO Conference Appearances - Quiver Quantitative
When Will Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Become Profitable? - 富途牛牛
Why Tenaya Therapeutics Inc. stock appeals to analystsDay Trade & AI Powered Market Trend Analysis - newser.com
Tenaya Therapeutics (NASDAQ:TNYA) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference - The Manila Times
Fireside chat Oct 14: Tenaya Therapeutics CEO Faraz Ali at H.C. Wainwright; 1x1 meetings Oct 15, replay 30 days - Stock Titan
Can Tenaya Therapeutics’ Leadership Messaging Shape Long-Term Perceptions and Value Creation for TNYA? - Yahoo Finance
Using RSI to spot recovery in Tenaya Therapeutics Inc.Earnings Beat & Accurate Technical Buy Alerts - newser.com
How Might Tenaya Therapeutics' (TNYA) Industry Visibility Influence Its Strategic Positioning? - Sahm
Is now a turning point for Tenaya Therapeutics Inc.July 2025 Update & Trade Opportunity Analysis - newser.com
Does Tenaya Therapeutics Inc. fit your quant trading model2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
What recovery options are there for Tenaya Therapeutics Inc.Trade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com
Tenaya Therapeutics CEO Faraz Ali to Speak at Upcoming Investor and Industry Conferences in October 2025 - Quiver Quantitative
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences - The Manila Times
Oct 6 & Oct 21: Tenaya Therapeutics CEO Faraz Ali to Present at Investor Conferences — Webcast Archived 30 Days - Stock Titan
Will Strategic Partnerships Propel SP Refractories Limited Higher in YEARExit Strategy Tips & Maximize Returns With Insights - earlytimes.in
Tenaya Therapeutics Inc Azioni (TNYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tenaya Therapeutics Inc Azioni (TNYA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer |
Aug 18 '25 |
Sale |
1.25 |
5,053 |
6,331 |
172,803 |
| Ali Faraz | Chief Executive Officer |
Aug 18 '25 |
Sale |
1.25 |
14,533 |
18,210 |
302,792 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):